As of Sep 23
| -0.29 / -0.32%|
The 16 analysts offering 12-month price forecasts for Incyte Corp have a median target of 99.50, with a high estimate of 106.00 and a low estimate of 87.00. The median estimate represents a +11.82% increase from the last price of 88.98.
The current consensus among 19 polled investment analysts is to Buy stock in Incyte Corp. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.